{"id":"https://openalex.org/W8810411","doi":null,"title":"Pharmacotherapeutic approach to the treatment of addiction: persistent challenges.","display_name":"Pharmacotherapeutic approach to the treatment of addiction: persistent challenges.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W8810411","mag":"8810411","pmid":"https://pubmed.ncbi.nlm.nih.gov/20806841","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2964348"},"language":"en","primary_location":{"id":"mag:8810411","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/articles/PMC2964348","pdf_url":null,"source":{"id":"https://openalex.org/S2755172918","display_name":"Missouri medicine","issn_l":"0026-6620","issn":["0026-6620"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Missouri medicine","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W8810411"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2964348/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025165610","display_name":"Daniel S. Zahm","orcid":"https://orcid.org/0000-0002-2943-7906","observed_orcids":["https://orcid.org/0000-0002-2943-7906"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel S Zahm","raw_affiliation_strings":["Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, USA. zahmds@slu.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, USA. zahmds@slu.edu","institution_ids":["https://openalex.org/I47838141"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025165610"],"corresponding_institution_ids":["https://openalex.org/I47838141"],"apc_list":null,"apc_paid":null,"fwci":0.3765,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.62288303,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"107","issue":"4","first_page":"276","last_page":"280"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.06909999996423721,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.7110000252723694},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/drugs-of-abuse","display_name":"drugs of abuse","score":0.5139999985694885},{"id":"https://openalex.org/keywords/drug-self-administration","display_name":"self-administration","score":0.8700000047683716},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.6470305919647217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38298100233078003},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.35811716318130493},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25003230571746826}],"mesh":[{"descriptor_ui":"D000427","descriptor_name":"Alcohol Deterrents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018682","descriptor_name":"GABA Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"mag:8810411","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/articles/PMC2964348","pdf_url":null,"source":{"id":"https://openalex.org/S2755172918","display_name":"Missouri medicine","issn_l":"0026-6620","issn":["0026-6620"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Missouri medicine","raw_type":null},{"id":"pmid:20806841","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20806841","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Missouri medicine","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2964348","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2964348/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mo Med","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2964348","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2964348/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mo Med","raw_type":"Text"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5695170684","display_name":"Convergent Versus Parallel Striatal Afferents","funder_award_id":"R01NS023805","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W190392689","https://openalex.org/W1487599137","https://openalex.org/W1492294380","https://openalex.org/W1514572922","https://openalex.org/W1974504536","https://openalex.org/W1980839482","https://openalex.org/W1994001725","https://openalex.org/W2006691722","https://openalex.org/W2007653857","https://openalex.org/W2009243814","https://openalex.org/W2021594631","https://openalex.org/W2021782736","https://openalex.org/W2033717313","https://openalex.org/W2040903782","https://openalex.org/W2044367989","https://openalex.org/W2054749214","https://openalex.org/W2060937634","https://openalex.org/W2066848874","https://openalex.org/W2070796637","https://openalex.org/W2090481799","https://openalex.org/W2098304576","https://openalex.org/W2106719141","https://openalex.org/W2106862702","https://openalex.org/W2126502833","https://openalex.org/W2129530731","https://openalex.org/W2162992969","https://openalex.org/W2165398609","https://openalex.org/W2169715811","https://openalex.org/W2171592578","https://openalex.org/W2398038833","https://openalex.org/W4246659915"],"related_works":["https://openalex.org/W2141125149","https://openalex.org/W2181587255","https://openalex.org/W2336983869","https://openalex.org/W2049474734","https://openalex.org/W1569294042","https://openalex.org/W2161718761","https://openalex.org/W293699658","https://openalex.org/W1537892738","https://openalex.org/W4213461946","https://openalex.org/W2033290021"],"abstract_inverted_index":{"The":[0],"sequence":[1],"of":[2,8,19,25,36,46,69],"pathophysiological":[3],"responses":[4],"to":[5,38],"repeated":[6],"self-administration":[7],"addictive":[9],"compounds":[10],"is":[11,30,56],"briefly":[12],"described,":[13],"as":[14,50],"are":[15],"prospects":[16],"for":[17,21],"development":[18],"drugs":[20],"addiction":[22],"and":[23],"some":[24],"those":[26],"currently":[27],"available.":[28],"It":[29,55],"noted":[31,57],"that":[32,59],"the":[33,44,62,67],"varying":[34],"vulnerability":[35],"individuals":[37],"addictions":[39],"creates":[40],"ethical":[41],"concerns":[42],"regarding":[43],"application":[45],"drug":[47],"abuse":[48],"pharmacotherapies":[49],"they":[51],"become":[52],"more":[53],"efficacious.":[54],"further":[58],"relapse":[60],"remains":[61],"most":[63],"persistent":[64],"challenge":[65],"in":[66],"treatment":[68],"addictions.":[70]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W8810411","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
